Related Experiment Videos

Neutrophils and lung injury: getting it right

Thomas R Martin¹

¹The Medical Research Service of the VA Puget Sound Medical Center, Seattle, Washington, USA. trmartin@u.washington.edu

The Journal of Clinical Investigation

|December 5, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Anti-CD14 treatment in patients with severe COVID-19: Clinical and biological effects in a Phase 2 randomized open-label adaptive platform clinical trial.

CHEST critical care·2025

Neutrophil reduction attenuates the severity of lung injury in the early phase of pneumococcal pneumonia in mice.

American journal of physiology. Lung cellular and molecular physiology·2024

A New Global Definition of Acute Respiratory Distress Syndrome.

American journal of respiratory and critical care medicine·2023

Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia.

EBioMedicine·2023

Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19.

Critical care explorations·2022

New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021.

American journal of respiratory cell and molecular biology·2022

See all related articles